Table 1.
PBMC PERCENTAGE ± SD | |||||
---|---|---|---|---|---|
T (CD3+CD161a−) | B (CD3−CD45RA+) | NK (CD3−CD161a+) | T (CD3+CD4+CD8−) | T (CD3+CD4−CD8+) | |
SHAM | 40.3 ± 4.1 | 22,8 ± 2.3 | 18.4 ± 1.1 | 72.8 ± 6.7 | 27.2 ± 4.3 |
6OHDA | 44.9 ± 2.9 | 21,3 ± 1.2 | 21.2 ± 1.8 | 65.2 ± 5.1 | 34.8 ± 2.2 *** |
DBS | 40.3 ± 2.4 | 16,3 ± 1.0 ** | 28.6 ± 2.8 ** | 74.9 ± 6.1 | 25.1 ± 2.7; ### |
DBS-6OHDA | 42.8 ± 4.3 | 16,9 ± 1.3 * | 25.9 ± 2.5 * | 70.5 ± 3.9 | 29.5 ± 1.7 ***; ## |
Explanations:
***p ≤ 0.001, **p ≤ 0.01, *p ≤ 0.05 – difference vs. SHAM group; ##p ≤ 0.01; #p ≤ 0.05 – difference vs. 6OHDA group; Tukey post hoc after one-way ANOVA